Published by Iain Gilbert on 28th April 2026
(Sharecast News) - Pharmaceutical giant GSK said on Tuesday that the US Food and Drug Administration had accepted its new drug application for bepirovirsen for priority review, with the drug being assessed as a potential treatment for adults with chronic hepatitis B.
URL: http://www.digitallook.com/dl/news/story/35893942/...